What do 'omic technologies have to offer periodontal clinical practice in the future?

Journal of Periodontal Research

Volumn 47, Issue 1, 2012, Pages 2-14

  Grant, M M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Genomics; Metabolomics; Periodontology; Proteomics; Systems biology; Transcriptomics

Indexed keywords

TRANSCRIPTOME;

BIOLOGY; GENOMICS; HUMAN; MEDICAL TECHNOLOGY; METABOLOMICS; PERIODONTAL DISEASE; PERIODONTICS; PROTEOMICS; REVIEW; SYSTEMS BIOLOGY;

BIOMEDICAL TECHNOLOGY; COMPUTATIONAL BIOLOGY; GENOMICS; HUMANS; METABOLOMICS; PERIODONTAL DISEASES; PERIODONTICS; PROTEOMICS; SYSTEMS BIOLOGY; TRANSCRIPTOME;

EID: 84855358370     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01387.x     Document Type: Review

References (161)

1. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-1820.
2. ATP Consulting Ltd. Adult Periodontal Disease Cost Analysis, a Report Commissioned by Listerine. ATP Consulting Ltd, 2008. (accessed on 03 June 2011).
3. Bensalah K, Montorsi F, Shariat SF. Challenges of cancer biomarker profiling. Eur Urol 2007;52:1601-1609.
4. Chapple IL. Periodontal disease diagnosis: current status and future developments. J Dent 1997;25:3-15.
5. Loos BG, Tjoa S. Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontol 2000 2005;39:53-72.
6. Listgarten J, Emili A. Practical proteomic biomarker discovery: taking a step back to leap forward. Drug Discov Today 2005;10:1697-1702.
7. Zhang L, Henson BS, Camargo PM, Wong DT. The clinical value of salivary biomarkers for periodontal disease. Periodontol 2000 2009;51:25-37.
8. Oppenheim FG, Salih E, Siqueira WL, Zhang W, Helmerhorst EJ. Salivary proteome and its genetic polymorphisms. Ann N Y Acad Sci 2007;1098:22-50.
9. Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta 2004;343:1-16.
10. Taba M Jr, Kinney J, Kim AS, Giannobile WV. Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am 2005;49:551-571, vi.
11. Chapple IL, Glenwright HD, Matthews JB, Thorpe GH, Lumley PJ. Site-specific alkaline phosphatase levels in gingival crevicular fluid in health and gingivitis: cross-sectional studies. J Clin Periodontol 1994;21:409-414.
12. Chapple IL, Socransky SS, Dibart S, Glenwright HD, Matthews JB. Chemiluminescent assay of alkaline phosphatase in human gingival crevicular fluid: investigations with an experimental gingivitis model and studies on the source of the enzyme within crevicular fluid. J Clin Periodontol 1996;23:587-594.
13. Chapple IL, Garner I, Saxby MS, Moscrop H, Matthews JB. Prediction and diagnosis of attachment loss by enhanced chemiluminescent assay of crevicular fluid alkaline phosphatase levels. J Clin Periodontol 1999;26:190-198.
14. Hanioka T, Takaya K, Matsumori Y, Matsuse R, Shizukuishi S. Relationship of the substance P to indicators of host response in human gingival crevicular fluid. J Clin Periodontol 2000;27:262-266.
15. Nakashima K, Giannopoulou C, Andersen E et al. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol 1996;23:832-838.
16. Nakashima K, Roehrich N, Cimasoni G. Osteocalcin, prostaglandin E2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. J Clin Periodontol 1994;21:327-333.
17. Wright HJ, Chapple IL, Matthews JB. Levels of TGFbeta1 in gingival crevicular fluid during a 21-day experimental model of gingivitis. Oral Dis 2003;9:88-94.
18. Grbic JT, Lamster IB, Fine JB et al. Changes in gingival crevicular fluid levels of immunoglobulin A following therapy: association with attachment loss. J Periodontol 1999;70:1221-1227.
19. Grbic JT, Singer RE, Jans HH, Celenti RS, Lamster IB. Immunoglobulin isotypes in gingival crevicular fluid: possible protective role of IgA. J Periodontol 1995;66:55-61.
20. Lamster IB. Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann Periodontol 1997;2:123-137.
21. Lamster IB, Celenti R, Ebersole JL. The relationship of serum IgG antibody titers to periodontal pathogens to indicators of the host response in crevicular fluid. J Clin Periodontol 1990;17:419-425.
22. Lamster IB, Harper DS, Fiorello LA, Oshrain RL, Celenti RS, Gordon JM. Lysosomal and cytoplasmic enzyme activity, crevicular fluid volume, and clinical parameters characterizing gingival sites with shallow to intermediate probing depths. J Periodontol 1987;58:614-621.
23. Lamster IB, Holmes LG, Gross KB et al. The relationship of beta-glucuronidase activity in crevicular fluid to probing attachment loss in patients with adult periodontitis. Findings from a multicenter study. J Clin Periodontol 1995;22:36-44.
24. Lamster IB, Oshrain RL, Harper DS, Celenti RS, Hovliaras CA, Gordon JM. Enzyme activity in crevicular fluid for detection and prediction of clinical attachment loss in patients with chronic adult periodontitis. Six month results. J Periodontol 1988;59:516-523.
25. Lamster IB, Wallenstein S, Sengupta S, Duffy T. Within-mouth correlations for indicators of the host response in gingival crevicular fluid. Arch Oral Biol 1990;35:779-783.
26. Wolff LF, Koller NJ, Smith QT, Mathur A, Aeppli D. Subgingival temperature: relation to gingival crevicular fluid enzymes, cytokines, and subgingival plaque micro-organisms. J Clin Periodontol 1997;24:900-906.
27. Chen HY, Cox SW, Eley BM. Cathepsin B, alpha2-macroglobulin and cystatin levels in gingival crevicular fluid from chronic periodontitis patients. J Clin Periodontol 1998;25:34-41.
28. Cox SW, Eley BM. Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid. A comparison of levels before and after basic periodontal treatment of chronic periodontitis patients. J Clin Periodontol 1992;19:333-339.
29. Eley BM, Cox SW. The relationship between gingival crevicular fluid cathepsin B activity and periodontal attachment loss in chronic periodontitis patients: a 2-year longitudinal study. J Periodontal Res 1996;31:381-392.
30. Ichimaru E, Tanoue M, Tani M et al. Cathepsin B in gingival crevicular fluid of adult periodontitis patients: identification by immunological and enzymological methods. Inflamm Res 1996;45:277-282.
31. Kennett CN, Cox SW, Eley BM. Investigations into the cellular contribution to host tissue proteases and inhibitors in gingival crevicular fluid. J Clin Periodontol 1997;24:424-431.
32. Kunimatsu K, Yamamoto K, Ichimaru E, Kato Y, Kato I. Cathepsins B, H and L activities in gingival crevicular fluid from chronic adult periodontitis patients and experimental gingivitis subjects. J Periodontal Res 1990;25:69-73.
33. Buduneli N, Vardar S, Atilla G, Sorsa T, Luoto H, Baylas H. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. J Periodontol 2002;73:103-109.
34. Golub LM, Siegel K, Ramamurthy NS, Mandel ID. Some characteristics of collagenase activity in gingival crevicular fluid and its relationship to gingival diseases in humans. J Dent Res 1976;55:1049-1057.
35. Kiili M, Cox SW, Chen HY et al. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 2002;29:224-232.
36. Kinane DF, Darby IB, Said S et al. Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res 2003;38:400-404.
37. Lee W, Aitken S, Kulkarni G et al. Collagenase activity in recurrent periodontitis: relationship to disease progression and doxycycline therapy. J Periodontal Res 1991;26:479-485.
38. Lee W, Aitken S, Sodek J, McCulloch CA. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodontal Res 1995;30:23-33.
39. Liu CM, Hou LT. Collagenase activity in the gingival crevicular fluid of periodontal patients. J Formos Med Assoc 1993;92:157-164.
40. Mancini S, Romanelli R, Laschinger CA, Overall CM, Sodek J, McCulloch CA. Assessment of a novel screening test for neutrophil collagenase activity in the diagnosis of periodontal diseases. J Periodontol 1999;70:1292-1302.
41. Nakamura T, Kido J, Kido R et al. The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients. J Periodontol 2000;71:361-367.
42. Nomura T, Ishii A, Oishi Y, Kohma H, Hara K. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases. Oral Dis 1998;4:231-240.
43. Persson L, Bergstrom J, Gustafsson A. Effect of tobacco smoking on neutrophil activity following periodontal surgery. J Periodontol 2003;74:1475-1482.
44. Romanelli R, Mancini S, Laschinger C, Overall CM, Sodek J, McCulloch CA. Activation of neutrophil collagenase in periodontitis. Infect Immun 1999;67:2319-2326.
45. Teng YT, Sodek J, McCulloch CA. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J Periodontal Res 1992;27:544-552.
46. Gazi MI, Cox SW, Clark DT, Eley BM. Comparison of host tissue and bacterial dipeptidyl peptidases in human gingival crevicular fluid by analytical isoelectric focusing. Arch Oral Biol 1995;40:731-736.
47. Armitage GC, Jeffcoat MK, Chadwick DE et al. Longitudinal evaluation of elastase as a marker for the progression of periodontitis. J Periodontol 1994;65:120-128.
48. Bader HI, Boyd RL. Long-term monitoring of adult periodontitis patients in supportive periodontal therapy: correlation of gingival crevicular fluid proteases with probing attachment loss. J Clin Periodontol 1999;26:99-105.
49. Darany DG, Beck FM, Walters JD. The relationship of gingival fluid leukocyte elastase activity to gingival fluid flow rate. J Periodontol 1992;63:743-747.
50. Figueredo CM, Areas A, Miranda LA, Fischer RG, Gustafsson A. The short-term effectiveness of non-surgical treatment in reducing protease activity in gingival crevicular fluid from chronic periodontitis patients. J Clin Periodontol 2004;31:615-619.
51. Figueredo CM, Gustafsson A. Activity and inhibition of elastase in GCF. J Clin Periodontol 1998;25:531-535.
52. Giannopoulou C, Andersen E, Demeurisse C, Cimasoni G. Neutrophil elastase and its inhibitors in human gingival crevicular fluid during experimental gingivitis. J Dent Res 1992;71:359-363.
53. Gustafsson A, Asman B, Bergstrom K. Altered relation between granulocyte elastase and alpha-2-macroglobulin in gingival crevicular fluid from sites with periodontal destruction. J Clin Periodontol 1994;21:17-21.
54. Gustafsson A, Asman B, Bergstrom K. Elastase and lactoferrin in gingival crevicular fluid: possible indicators of a granulocyte-associated specific host response. J Periodontal Res 1994;29:276-282.
55. Gustafsson A, Asman B, Bergstrom K, Soder PO. Granulocyte elastase in gingival crevicular fluid. A possible discriminator between gingivitis and periodontitis. J Clin Periodontol 1992;19:535-540.
56. Herrmann JM, Gonzales JR, Boedeker RH, Vonholdt J, Meyle J. Microassay for the detection of elastase activity in the gingival crevice. J Clin Periodontol 2001;28:31-37.
57. Ingman T, Sorsa T, Kangaspunta P, Konttinen YT. Elastase and alpha-1-proteinase inhibitor in gingival crevicular fluid and gingival tissue in adult and juvenile periodontitis. J Periodontol 1994;65:702-709.
58. Jin L, Soder B, Corbet EF. Interleukin-8 and granulocyte elastase in gingival crevicular fluid in relation to periodontopathogens in untreated adult periodontitis. J Periodontol 2000;71:929-939.
59. Jin LJ, Soder PO, Asman B, Bergstrom K. Granulocyte elastase in gingival crevicular fluid: improved monitoring of the site-specific response to treatment in patients with destructive periodontitis. J Clin Periodontol 1995;22:240-246.
60. Jin LJ, Soder PO, Leung WK et al. Granulocyte elastase activity and PGE2 levels in gingival crevicular fluid in relation to the presence of subgingival periodontopathogens in subjects with untreated adult periodontitis. J Clin Periodontol 1999;26:531-540.
61. Murray MC, Mooney J, Kinane DF. The relationship between elastase and lactoferrin in healthy, gingivitis and periodontitis sites. Oral Dis 1995;1:106-109.
62. Nakamura-Minami M, Furuichi Y, Ishikawa K, Mitsuzono-Tofuku Y, Izumi Y. Changes of alpha1-protease inhibitor and secretory leukocyte protease inhibitor levels in gingival crevicular fluid before and after non-surgical periodontal treatment. Oral Dis 2003;9:249-254.
63. Palcanis KG, Larjava IK, Wells BR et al. Elastase as an indicator of periodontal disease progression. J Periodontol 1992;63:237-242.
64. Persson L, Bergstrom J, Gustafsson A, Asman B. Tobacco smoking and gingival neutrophil activity in young adults. J Clin Periodontol 1999;26:9-13.
65. Persson L, Bergstrom J, Ito H, Gustafsson A. Tobacco smoking and neutrophil activity in patients with periodontal disease. J Periodontol 2001;72:90-95.
66. Smith QT, Harriman L, Au GS et al. Neutrophil elastase in crevicular fluid: comparison of a middle-aged general population with healthy and periodontitis groups. J Clin Periodontol 1995;22:935-941.
67. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 2011;40:387-426.
68. Parahitiyawa NB, Scully C, Leung WK, Yam WC, Jin LJ, Samaranayake LP. Exploring the oral bacterial flora: current status and future directions. Oral Dis 2010;16:136-145.
69. Dewhirst FE, Chen T, Izard J et al. The human oral microbiome. J Bacteriol 2010;192:5002-5017.
70. Wade WG. Has the use of molecular methods for the characterization of the human oral microbiome changed our understanding of the role of bacteria in the pathogenesis of periodontal disease? J Clin Periodontol 2011;38(suppl 11):7-16.
71. Pozhitkov AE, Beikler T, Flemmig T, Noble PA. High-throughput methods for analysis of the human oral microbiome. Periodontol 2000 2000;55:70-86.
72. Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
73. Jones OA, Cheung VL. An introduction to metabolomics and its potential application in veterinary science. Comp Med 2007;57:436-442.
74. Steiner M, Hodes MZ, Shreve M, Sundberg S, Edson JR. Postoperative stroke in a child with cerebral palsy heterozygous for factor V Leiden. J Pediatr Hematol Oncol 2000;22:262-264.
75. Takashiba S, Naruishi K. Gene polymorphisms in periodontal health and disease. Periodontol 2000 2006;40:94-106.
76. Nielsen R. Population genetic analysis of ascertained SNP data. Hum Genomics 2004;1:218-224.
77. Kim YJ, Viana AC, Curtis KM et al. Association of haplotypes in the IL8 gene with susceptibility to chronic periodontitis in a Brazilian population. Clin Chim Acta 2010;411:1264-1268.
78. Scapoli C, Borzani I, Guarnelli ME et al. IL-1 gene cluster is not linked to aggressive periodontitis. J Dent Res 2010;89:457-461.
79. Cury PR, Horewicz VV, Ferrari DS et al. Evaluation of the effect of tumor necrosis factor-alpha gene polymorphism on the risk of peri-implantitis: a case-control study. Int J Oral Maxillofac Implants 2009;24:1101-1105.
80. Shete AR, Joseph R, Vijayan NN, Srinivas L, Banerjee M. Association of single nucleotide gene polymorphism at interleukin-1beta +3954, -511, and -31 in chronic periodontitis and aggressive periodontitis in Dravidian ethnicity. J Periodontol 2010;81:62-69.
81. Noack B, Gorgens H, Lorenz K, Schackert HK, Hoffmann T. TLR4 and IL-18 gene variants in chronic periodontitis: impact on disease susceptibility and severity. Immunol Invest 2009;38:297-310.
82. Lopez NJ, Valenzuela CY, Jara L. Interleukin-1 gene cluster polymorphisms associated with periodontal disease in type 2 diabetes. J Periodontol 2009;80:1590-1598.
83. Saleh TA, Stephen L, Kotze M, Pretorius A. The composite interleukin-1 genotype in South Africa. SADJ 2009;64:170-173.
84. Xiao LM, Yan YX, Xie CJ et al. Association among interleukin-6 gene polymorphism, diabetes and periodontitis in a Chinese population. Oral Dis 2009;15:547-553.
85. Kim YJ, Viana AC, Curtis KM, Orrico SR, Cirelli JA, Scarel-Caminaga RM. Lack of association of a functional polymorphism in the interleukin 8 gene with susceptibility to periodontitis. DNA Cell Biol 2009;28:185-190.
86. Kaarthikeyan G, Jayakumar ND, Padmalatha O, Sheeja V, Sankari M, Anandan B. Analysis of the association between interleukin-1beta (+3954) gene polymorphism and chronic periodontitis in a sample of the south Indian population. Indian J Dent Res 2009;20:37-40.
87. Hu KF, Huang KC, Ho YP et al. Interleukin-10 (-592 C/A) and interleukin-12B (+16974 A/C) gene polymorphisms and the interleukin-10 ATA haplotype are associated with periodontitis in a Taiwanese population. J Periodontal Res 2009;44:378-385.
88. Nibali L, D'Aiuto F, Donos N et al. Association between periodontitis and common variants in the promoter of the interleukin-6 gene. Cytokine 2009;45:50-54.
89. Andreiotelli M, Koutayas SO, Madianos PN, Strub JR. Relationship between interleukin-1 genotype and peri-implantitis: a literature review. Quintessence Int 2008;39:289-298.
90. Trombone AP, Cardoso CR, Repeke CE et al. Tumor necrosis factor-alpha -308G/A single nucleotide polymorphism and red-complex periodontopathogens are independently associated with increased levels of tumor necrosis factor-alpha in diseased periodontal tissues. J Periodontal Res 2009;44:598-608.
91. Noack B, Gorgens H, Lorenz K, Ziegler A, Hoffmann T, Schackert HK. TLR4 and IL-18 gene variants in aggressive periodontitis. J Clin Periodontol 2008;35:1020-1026.
92. Holla LI, Fassmann A, Augustin P, Halabala T, Znojil V, Vanek J. The association of interleukin-4 haplotypes with chronic periodontitis in a Czech population. J Periodontol 2008;79:1927-1933.
93. Claudino M, Trombone AP, Cardoso CR et al. The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J Leukoc Biol 2008;84:1565-1573.
94. Fiebig A, Jepsen S, Loos BG et al. Polymorphisms in the interleukin-1 (IL1) gene cluster are not associated with aggressive periodontitis in a large Caucasian population. Genomics 2008;92:309-315.
95. Ferreira SB Jr, Trombone AP, Repeke CE et al. An interleukin-1beta (IL-1beta) single-nucleotide polymorphism at position 3954 and red complex periodontopathogens independently and additively modulate the levels of IL-1beta in diseased periodontal tissues. Infect Immun 2008;76:3725-3734.
96. Cullinan MP, Westerman B, Hamlet SM et al. Progression of periodontal disease and interleukin-10 gene polymorphism. J Periodontal Res 2008;43:328-333.
97. Akman A, Sallakci N, Kacaroglu H et al. Relationship between periodontal findings and the TNF-alpha Gene 1031T/C polymorphism in Turkish patients with Behcet's disease. J Eur Acad Dermatol Venereol 2008;22:950-957.
98. Takeuchi-Hatanaka K, Ohyama H, Nishimura F et al. Polymorphisms in the 5' flanking region of IL12RB2 are associated with susceptibility to periodontal diseases in the Japanese population. J Clin Periodontol 2008;35:317-323.
99. Komatsu Y, Galicia JC, Kobayashi T, Yamazaki K, Yoshie H. Association of interleukin-1 receptor antagonist +2018 gene polymorphism with Japanese chronic periodontitis patients using a novel genotyping method. Int J Immunogenet 2008;35:165-170.
100. Struch F, Dau M, Schwahn C, Biffar R, Kocher T, Meisel P. Interleukin-1 gene polymorphism, diabetes, and periodontitis: results from the Study of Health in Pomerania (SHIP). J Periodontol 2008;79:501-507.
101. Nibali L, Griffiths GS, Donos N et al. Association between interleukin-6 promoter haplotypes and aggressive periodontitis. J Clin Periodontol 2008;35:193-198.
102. Mellati E, Arab HR, Tavakkol-Afshari J, Ebadian AR, Radvar M. Analysis of -1082 IL-10 gene polymorphism in Iranian patients with generalized aggressive periodontitis. Med Sci Monit 2007;13:CR510-CR514.
103. Akman A, Ekinci NC, Kacaroglu H, Yavuzer U, Alpsoy E, Yegin O. Relationship between periodontal findings and specific polymorphisms of interleukin-1alpha and -1beta in Turkish patients with Behcet's disease. Arch Dermatol Res 2008;300:19-26.
104. Kara N, Keles GC, Sumer P et al. Association of the polymorphisms in promoter and intron regions of the interleukin-4 gene with chronic periodontitis in a Turkish population. Acta Odontol Scand 2007;65:292-297.
105. Maria de Freitas N, Imbronito AV, Neves AC, Nunes FD, Pustiglioni FE, Lotufo RF. Analysis of IL-1A(-889) and TNFA(-308) gene polymorphism in Brazilian patients with generalized aggressive periodontitis. Eur Cytokine Netw 2007;18:142-147.
106. Gonzales JR, Mann M, Stelzig J, Bodeker RH, Meyle J. Single-nucleotide polymorphisms in the IL-4 and IL-13 promoter region in aggressive periodontitis. J Clin Periodontol 2007;34:473-479.
107. Tervonen T, Raunio T, Knuuttila M, Karttunen R. Polymorphisms in the CD14 and IL-6 genes associated with periodontal disease. J Clin Periodontol 2007;34:377-383.
108. Sumer AP, Kara N, Keles GC, Gunes S, Koprulu H, Bagci H. Association of interleukin-10 gene polymorphisms with severe generalized chronic periodontitis. J Periodontol 2007;78:493-497.
109. Savarrio L, Donati M, Carr C, Kinane DF, Berglundh T. Interleukin-24, RANTES and CCR5 gene polymorphisms are not associated with chronic adult periodontitis. J Periodontal Res 2007;42:152-158.
110. Babel N, Cherepnev G, Babel D et al. Analysis of tumor necrosis factor-alpha, transforming growth factor-beta, interleukin-10, IL-6, and interferon-gamma gene polymorphisms in patients with chronic periodontitis. J Periodontol 2006;77:1978-1983.
111. Agrawal AA, Kapley A, Yeltiwar RK, Purohit HJ. Assessment of single nucleotide polymorphism at IL-1A+4845 and IL-1B+3954 as genetic susceptibility test for chronic periodontitis in Maharashtrian ethnicity. J Periodontol 2006;77:1515-1521.
112. Galicia JC, Tai H, Komatsu Y, Shimada Y, Ikezawa I, Yoshie H. Interleukin-6 receptor gene polymorphisms and periodontitis in a non-smoking Japanese population. J Clin Periodontol 2006;33:704-709.
113. Jansson H, Lyssenko V, Gustavsson A et al. Analysis of the interleukin-1 and interleukin-6 polymorphisms in patients with chronic periodontitis. A pilot study. Swed Dent J 2006;30:17-23.
114. Suzuki A, Ji G, Numabe Y, Ishii K, Muramatsu M, Kamoi K. Large-scale investigation of genomic markers for severe periodontitis. Odontology 2004;92:43-47.
115. Michalowicz BS, Aeppli D, Virag JG et al. Periodontal findings in adult twins. J Periodontol 1991;62:293-299.
116. Schaefer AS, Richter GM, Nothnagel M et al. A genome-wide association study identifies GLT6D1 as a susceptibility locus for periodontitis. Hum Mol Genet 2010;19:553-562.
117. Papapanou PN, Abron A, Verbitsky M et al. Gene expression signatures in chronic and aggressive periodontitis: a pilot study. Eur J Oral Sci 2004;112:216-223.
118. Demmer RT, Behle JH, Wolf DL et al. Transcriptomes in healthy and diseased gingival tissues. J Periodontol 2008;79:2112-2124.
119. Papapanou PN, Behle JH, Kebschull M et al. Subgingival bacterial colonization profiles correlate with gingival tissue gene expression. BMC Microbiol 2009;9:221.
120. Kebschull M, Demmer R, Behle JH et al. Granulocyte chemotactic protein 2 (gcp-2/cxcl6) complements interleukin-8 in periodontal disease. J Periodontal Res 2009;44:465-471.
121. Offenbacher S, Barros SP, Paquette DW et al. Gingival transcriptome patterns during induction and resolution of experimental gingivitis in humans. J Periodontol 2009;80:1963-1982.
122. Beikler T, Peters U, Prior K, Eisenacher M, Flemmig TF. Gene expression in periodontal tissues following treatment. BMC Med Genomics 2008;1:30.
123. Kim DM, Ramoni MF, Nevins M, Fiorellini JP. The gene expression profile in refractory periodontitis patients. J Periodontol 2006;77:1043-1050.
124. Papapanou PN, Sedaghatfar MH, Demmer RT et al. Periodontal therapy alters gene expression of peripheral blood monocytes. J Clin Periodontol 2007;34:736-747.
125. Matthews JB, Wright HJ, Roberts A, Ling-Mountford N, Cooper PR, Chapple IL. Neutrophil hyper-responsiveness in periodontitis. J Dent Res 2007;86:718-722.
126. Matthews JB, Wright HJ, Roberts A, Cooper PR, Chapple IL. Hyperactivity and reactivity of peripheral blood neutrophils in chronic periodontitis. Clin Exp Immunol 2007;147:255-264.
127. Wright HJ, Matthews JB, Chapple IL, Ling-Mountford N, Cooper PR. Periodontitis associates with a type 1 IFN signature in peripheral blood neutrophils. J Immunol 2008;181:5775-5784.
128. de Pablo P, Dietrich T, McAlindon TE. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 2008;35:70-76.
129. de Pablo P, Chapple IL, Buckley CD, Dietrich T. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 2009;5:218-224.
130. Bartold PM, Marshall RI, Haynes DR. Periodontitis and rheumatoid arthritis: a review. J Periodontol 2005;76:2066-2074.
131. Lundy FT, Orr DF, Shaw C, Lamey PJ, Linden GJ. Detection of individual human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in unfractionated gingival crevicular fluid - a MALDI-MS approach. Mol Immunol 2005;42:575-579.
132. Dommisch H, Vorderwulbecke S, Eberhard J, Steglich M, Jepsen S. SELDI-TOF-MS of gingival crevicular fluid - a methodological approach. Arch Oral Biol 2009;54:803-809.
133. Pisano E, Cabras T, Montaldo C et al. Peptides of human gingival crevicular fluid determined by HPLC-ESI-MS. Eur J Oral Sci 2005;113:462-468.
134. Kojima T, Andersen E, Sanchez JC et al. Human gingival crevicular fluid contains MRP8 (S100A8) and MRP14 (S100A9), two calcium-binding proteins of the S100 family. J Dent Res 2000;79:740-747.
135. Ngo LH, Veith PD, Chen YY, Chen D, Darby IB, Reynolds EC. Mass spectrometric analyses of peptides and proteins in human gingival crevicular fluid. J Proteome Res 2010;9:1683-1693.
136. Wu Y, Shu R, Luo LJ, Ge LH, Xie YF. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. J Periodontal Res 2009;44:636-644.
137. Bostanci N, Heywood W, Mills K, Parkar M, Nibali L, Donos N. Application of label-free absolute quantitative proteomics in human gingival crevicular fluid by LC/MS E (gingival exudatome). J Proteome Res 2010;9:2191-2199.
138. Grant MM, Creese AJ, Barr G et al. Proteomic analysis of a noninvasive human model of acute inflammation and its resolution: the twenty-one day gingivitis model. J Proteome Res 2010;9:4732-4744.
139. Dias IH, Marshall L, Lambert PA, Chapple IL, Matthews JB, Griffiths HR. Gingipains from Porphyromonas gingivalis increase the chemotactic and respiratory burst-priming properties of the 77-amino-acid interleukin-8 variant. Infect Immun 2008;76:317-323.
140. Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF. The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol Immunol 2009;24:11-17.
141. Garg G, Pradeep AR, Thorat MK. Effect of nonsurgical periodontal therapy on crevicular fluid levels of Cathepsin K in periodontitis. Arch Oral Biol 2009;54:1046-1051.
142. Impens F, Colaert N, Helsens K et al. MS-driven protease substrate degradomics. Proteomics 2010;10:1284-1296.
143. Morrison CJ, Butler GS, Rodriguez D, Overall CM. Matrix metalloproteinase proteomics: substrates, targets, and therapy. Curr Opin Cell Biol 2009;21:645-653.
144. Brock GR, Butterworth CJ, Matthews JB, Chapple IL. Local and systemic total antioxidant capacity in periodontitis and health. J Clin Periodontol 2004;31:515-521.
145. Grant MM, Brock GR, Matthews JB, Chapple IL. Crevicular fluid glutathione levels in periodontitis and the effect of non-surgical therapy. J Clin Periodontol 2010;37:17-23.
146. Chapple IL, Mason GI, Garner I et al. Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem 1997; 34 (Pt 4): 412-421.
147. Barnes VM, Teles R, Trivedi HM et al. Acceleration of purine degradation by periodontal diseases. J Dent Res 2009;88:851-855.
148. Gronert K, Kantarci A, Levy BD et al. A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J Immunol 2004;172:1856-1861.
149. Fukushima A, Kusano M, Redestig H, Arita M, Saito K. Integrated omics approaches in plant systems biology. Curr Opin Chem Biol 2009;13:532-538.
150. Schadt EE, Lum PY. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Reverse engineering gene networks to identify key drivers of complex disease phenotypes. J Lipid Res 2006;47:2601-2613.
151. De Smet R, Marchal K. Advantages and limitations of current network inference methods. Nat Rev Microbiol 2010;8:717-729.
152. Covani U, Marconcini S, Giacomelli L, Sivozhelevov V, Barone A, Nicolini C. Bioinformatic prediction of leader genes in human periodontitis. J Periodontol 2008;79:1974-1983.
153. de Lillo A, Ashley FP, Palmer RM et al. Novel subgingival bacterial phylotypes detected using multiple universal polymerase chain reaction primer sets. Oral Microbiol Immunol 2006;21:61-68.
154. Keijser BJ, Zaura E, Huse SM et al. Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res 2008;87:1016-1020.
155. Nibali L, Donos N, Henderson B. Periodontal infectogenomics. J Med Microbiol 2009;58:1269-1274.
156. Prill RJ, Marbach D, Saez-Rodriguez J et al. Towards a rigorous assessment of systems biology models: the DREAM3 challenges. PLoS ONE 2010;5:e9202.
157. Alvarez MJ, Sumazin P, Rajbhandari P, Califano A. Correlating measurements across samples improves accuracy of large-scale expression profile experiments. Genome Biol 2009;10:R143.
158. Margolin AA, Nemenman I, Basso K et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 2006;7(suppl 1):S7.
159. Villoslada P, Steinman L, Baranzini SE. Systems biology and its application to the understanding of neurological diseases. Ann Neurol 2009;65:124-139.
160. Bandyopadhyay S, Mehta M, Kuo D et al. Rewiring of genetic networks in response to DNA damage. Science 2010;330:1385-1389.
161. Lim J, Hao T, Shaw C et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006;125:801-814.